CATEGORIES

Press Release

LATEST

TRENDING

EDITORS CHOICE

COVID-19 Testing with 72 Hour or Less Turnaround Time

TCA/GENETWORx is building capability to perform 870,000 tests per day or 26 million per month. In order to meet demand, the company launched a massive recruiting campaign called Re Employ America

Genome Editing and Cellular Therapies Show Promise for Treating Blood Disorders, Cancers

Three studies report promising results in the use of cutting-edge genome editing and cellular therapies for hard-to-treat blood disorders and cancers.

Impact of COVID-19 on the Respiratory Device Accessories Market

This report is built to visualize quantitative market trends within Anesthesia and Respiratory Devices therapeutic area. The model discusses in detail the impact of COVID-19 on Respiratory Devices

Reblozyl (luspatercept) Approved for Treatment of Transfusion-Dependent Anemia

European Commission Approves Reblozyl (luspatercept) for the Treatment of Transfusion-Dependent Anemia in Adult Patients with Myelodysplastic Syndromes or Beta Thalassemia